ISBN13: | 9781032223537 |
ISBN10: | 1032223537 |
Binding: | Paperback |
No. of pages: | 390 pages |
Size: | 229x152 mm |
Language: | English |
Illustrations: | 53 Illustrations, black & white; 43 Illustrations, color; 15 Halftones, black & white; 28 Halftones, color; 38 Line drawings, black & white; 15 Line drawings, color; 7 Tables, black & white |
700 |
Targeted Metallo-Drugs
GBP 47.99
Click here to subscribe.
This MILS-24 volume provides a comprehensive overview of recent advances in the development of new metal-based drugs as anti-cancer, anti-microbial and anti-viral agents which have been designed specifically to overcome toxic side effects and/or resistance issues associated with current drug treatments.
Volume 24, entitled Targeted Metallo-Drugs: Design, Development, and Modes of Action, of the series Metal Ions in Life Sciences (MILS), fosters inter-disciplinary research in the vibrant field of Biological Inorganic Chemistry. Inspired by the clinical success of cisplatin as a leading anticancer drug but mindful of the shortcomings associated with its use including dose-limiting toxic side effects and acquired or intrinsic drug resistance, scientists across the globe have been endeavoring to identify new metallo-drugs for therapeutic exploitation. This has led to innovative metallo-drug candidates that (i) enhance cancer cell selectivity, thus reducing toxic side effects, and/or (ii) possess new modes of action to improve efficacy and also target resistance pathways. This and more are captured in MILS- 24 which consists of 12 comprehensive, well-illustrated, and up to date chapters with over 1600 citations, 100 figures, and 10 tables with key contributions from 32 international experts from Europe, Asia, and North and South America. MILS- 24 not only keeps the scientific community abreast of latest developments, it also serves as an invaluable resource to stimulate further research on targeted metallo-drug design and development.
- It covers anticancer, antimicrobial, antiviral, and other agents, such as those targeting tropical diseases and cyanide poisoning and radiometals in molecular imaging and therapy
- It highlights recent metallo-drug developments targeting COVID-19
- It features advanced spectroscopic methods and metallomics as important tools to elucidate the modes of actions of metallo-drugs